Senti Biosciences Holdings, Inc.

Senti Biosciences Holdings, Inc. (Nasdaq: DYNS) is a publicly traded biotechnology company formed through the de-SPAC merger of Dynamics Special Purpose Corp, a blank-check acquisition vehicle that completed its initial public offering in 2021, and Senti Biosciences, a developer of gene circuit medicines. The combined entity operates in the biotechnology and life sciences sector, engineering programmable gene circuits designed to improve the precision and efficacy of cell and gene therapies for cancer and other complex diseases. Senti Biosciences Holdings filed an 8-K with the Securities and Exchange Commission on March 7, 2025. Sign up at SpacDesk to access complete filing histories, sponsor profiles, and deal analytics across the SPAC market.